Skip to main content
Veterinary Medicines

NOVARVILAP SUSPENSION INYECTABLE

Suspended
  • Rabbit haemorrhagic disease virus, type 2, strain GU2013, Inactivated

Product identification

Medicine name:
NOVARVILAP SUSPENSION INYECTABLE
Active substance:
  • Rabbit haemorrhagic disease virus, type 2, strain GU2013, Inactivated
Target species:
  • Rabbit (female for reproduction)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabbit haemorrhagic disease virus, type 2, strain GU2013, Inactivated
    80.00
    haemagglutinating units
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit (female for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AA01
Authorisation status:
  • Suspended
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Ovejero S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.U.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 3409 ESP
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 23/12/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 23/12/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 23/12/2025